Stocks · Korea 156100 KOSDAQ

L&k Biomed

6,780원 +7.45% Market cap 1,515억 2026-10-07 close
Data as of 2026-10-07 · Linked from 7 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR3.25x
EPS0 KRW
BPS2,087 KRW
ROE-15.70%
DPS0 KRW

Returns and 52-week range

1W+12.73%
1M+76.68%
3M+48.26%
6M-15.70%
1Y-22.15%
YTD-48.76%
52W high16,400원
52W low2,730원
From 52W high-58.41%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
2022198억-131억-162억-66.1%
2023299억20억-52억6.8%
2024361억31억92억8.5%
2025389억7억-168억1.8%
Quarterly
2024 4Q100억6억58억5.7%
2025 1Q89억-1억-7억-1.6%
2025 2Q113억17억-23억15.2%
2025 3Q101억3억26억3.4%
2025 4Q86억-12억-164억-13.9%
2026 1Q95억1억79억1.1%

Company

CEO강국진(단독대표)
Founded2008-12-22
Fiscal year end12
Address: 경기도 용인시 기흥구 동백중앙로16번길 16-25 201호 &nbsp

Peers in the same sector

CompanyMarket capP/EP/B1M
엠아이텍1,526억7.511.21-8.27%
메쥬1,476억35.4012.46-42.05%
이엘씨1,552억18.030.86+15.41%
시너지이노베이션1,414억45.860.67+1.89%
큐리오시스1,567억—5.55+24.64%
레이언스1,372억—0.55+16.81%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.